(Reuters) – The U.S. Food and Drug Administration said on Tuesday it may decline to review and process new emergency use authorization (EUA) requests for COVID-19 vaccines for the rest of the pandemic, if a company has not already begun discussions.So far, vaccines from Pfizer Inc, Moderna Inc and Johnson & Johnson have been authorized for emergency use in the United States. (https://bit.ly/3fOpP2S)Novavax Inc has had discussions with regulators and said it does not expect to seek regulatory authorization for its COVID-19 shot in the United States, Britain and Europe until the third quarter of 2021.

https://kfgo.com/2021/05/25/u-s-fda-may-not-review-new-covid-19-vaccine-eua-requests-during-pandemic/

#kfgo